-
公开(公告)号:AR110273A1
公开(公告)日:2019-03-13
申请号:ARP170103331
申请日:2017-11-29
Applicant: PHARMACYCLICS LLC
Inventor: POZZAN ALFONSO , CATALANI MARIA PIA , PEZZATI BERNARDO , RAVEGLIA LUCA FRANCESCO , KORMAN HENRY , DANDA JR FELIX , ZANALETTI RICCARDO , JIA ZHAOZHONG J , CHEN WEI
IPC: C07D403/12 , A61K31/407 , A61K31/4155 , A61K31/4184 , A61K31/4245 , A61K31/4427 , A61K31/4523 , A61K31/497 , A61K31/519 , A61K31/53 , A61P35/00 , A61P37/00 , C07D401/12 , C07D401/14 , C07D403/14 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/04 , C07D487/04
Abstract: Reivindicación 1: Un compuesto de fórmula (1), caracterizado porque: A¹ es fenilo sustituido o no sustituido o un heteroarilo de 5 - 10 miembros sustituido o no sustituido; A² es fenilo sustituido o no sustituido o un heteroarilo de 5 - 10 miembros sustituido o no sustituido; L¹ es -N(R⁴)C(O)-, -N(R⁴)-C(O)N(R⁴)-, -C(O)N(R⁴)-, -OC(O)-, o -C(O)O-; R¹ es H, alquilo C₁₋₆, halo, CN, cicloalquilo C₃₋₆, o heteroarilo, cada uno de los cuales es no sustituido o independientemente sustituido con uno o más sustituyentes seleccionados de halo e hidroxi; o A², L¹, y R¹, tomados juntos con los átomos a los cuales se unen, forman un heterociclilo bicíclico o tricíclico de 9 - 14 miembros el cual es no sustituido o sustituido con uno o más sustituyentes seleccionados de alquilo C₁₋₆, hidroxi, y carbonilo; W es N o C(H); R² es alquilo C₁₋₆, halo o -OH; Y es un enlace sencillo, o -L²-N(R³)C(O)-; Z es H, alquilo C₁₋₃ sustituido o no sustituido, alquenilo C₁₋₃ sustituido o no sustituido, alquinilo C₁₋₃ sustituido o no sustituido, cicloalquilo C₃₋₆ sustituido o no sustituido, heterocicloalquilo C₂₋₇ sustituido o no sustituido, arilo C₆₋₁₂ sustituido o no sustituido, o heteroarilo C₁₋₁₂ sustituido o no sustituido; cada R³ y R⁴ es independientemente H o alquilo C₁₋₆; L² es un enlace sencillo o -(CH₂)ₜ-; t es 1, 2, ó 3; m es 0 ó 1; y n es 0, 1, 2, ó 3; o una sal o estereoisómero del mismo farmacéuticamente aceptable; siempre que i) cuando R¹ es H, Me, Et, i-Pr, t-Bu, CF₃, ciclopropilo, CN, o halo; entonces A² es diferente de fenilo no sustituido; o ii) cuando R¹ es H, Me, Et, i-Pr, t-Bu, CF₃, ciclopropilo, CN, o halo; entonces Y es -N(H)C(O), y Z es alquenilo C₁₋₃ sustituido o no sustituido, o alquinilo C₁₋₃ sustituido o no sustituido.
-
公开(公告)号:HK1246293A1
公开(公告)日:2018-09-07
申请号:HK18105861
申请日:2018-05-07
Applicant: PHARMACYCLICS LLC , JANSSEN PHARMACEUTICA NV
Inventor: BENHAIM CYRIL , CHEN WEI , GOLDMAN ERICK , HORVATH ANDRAS , PYE PHILIP , SMYTH MARK S , VERNER ERIK J
IPC: C07D20060101
-
公开(公告)号:MA42623A
公开(公告)日:2018-06-20
申请号:MA42623
申请日:2016-06-02
Applicant: PHARMACYCLICS LLC
Inventor: ATALLAH GORDANA BABIC , CHEN WEI , JIA ZHAOZHONG J , POZZAN ALFONSO , RAVEGLIA LUCAL FRANCESCO , ZANALETTI RICCARDO
IPC: A61K31/497 , A61K31/53 , C07D403/12
-
公开(公告)号:SG11201705678YA
公开(公告)日:2017-08-30
申请号:SG11201705678Y
申请日:2016-01-14
Applicant: PHARMACYCLICS LLC , JANSSEN PHARMACEUTICA NV
Inventor: BENHAIM CYRIL , CHEN WEI , GOLDMAN ERICK , HORVATH ANDRAS , PYE PHILIP , SMYTH MARK S , VERNER ERIK J
IPC: C07D487/04
Abstract: Described herein is the synthesis of Bruton's tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one.
-
公开(公告)号:CR20160203A
公开(公告)日:2016-08-31
申请号:CR20160203
申请日:2014-09-29
Applicant: PHARMACYCLICS LLC
Inventor: LOURY DAVID J , CHEN WEI , WANG LONGCHENG , JIA ZHAOZHONG J
IPC: A61P19/02 , A61P19/00 , C07D401/14 , C07D403/14
Abstract: En la presente se describen compuestos que forman enlaces 15 covalentes con la tirosina cinasa de Bruton (Btk). También se describen inhibidores irreversibles de Btk. Además, también se describen los inhibidores reversibes de Btk. También se describen composiciones farmacéuticas que incluyen los compuestos. Se describen métodos para usar inhibidores de Btk, 20 solos o en combinación con otros agentes terapéuticos, para el tratamiento de enfermedades afecciones autoinmunitarias, enfermedades afecciones heteroinmunitarias, cáncer, inclusive linfoma y enfermedades afecciones inflamatorias.
-
公开(公告)号:AU2010306921C1
公开(公告)日:2016-03-17
申请号:AU2010306921
申请日:2010-10-12
Applicant: PHARMACYCLICS LLC
Inventor: CHEN WEI , LOURY DAVID J , MODY TARAK D , VERNER ERIK , SMYTH MARK STEPHEN , LUO WENCHEN
IPC: C07D401/04 , A61K31/519 , A61P19/02 , A61P19/10 , C07D401/14 , C07D487/04
Abstract: Described herein are kinase inhibitor compounds, methods for synthesizing such inhibitors, and methods for using such inhibitors in the treatment of diseases. Further described herein are methods, assays and systems for determining an appropriate inhibitor of a protein, including a kinase.
-
公开(公告)号:AU2013245503B2
公开(公告)日:2015-09-24
申请号:AU2013245503
申请日:2013-10-17
Applicant: PHARMACYCLICS LLC
Inventor: LOURY DAVID , VERNER ERIK , CHEN WEI , HONIGBERG LEE , BUGGY JOSEPH
Abstract: Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
-
公开(公告)号:CA2932609A1
公开(公告)日:2015-06-11
申请号:CA2932609
申请日:2014-12-03
Applicant: PHARMACYCLICS LLC
Inventor: JIA ZHAOZHONG J , THOMAS WILLIAM D , CHEN WEI
IPC: C07D403/12 , A61K31/497 , A61K31/53 , A61P19/00 , A61P35/00 , A61P37/00 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
Abstract: Disclosed herein are reversible and irreversible inhibitors of Bruton's tyrosine kinase (Btk). Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are described, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
-
公开(公告)号:AU2008232762B2
公开(公告)日:2013-09-19
申请号:AU2008232762
申请日:2008-03-27
Applicant: PHARMACYCLICS LLC
Inventor: VERNER ERIK , LOURY DAVID , HONIGBERG LEE , CHEN WEI , BUGGY JOSEPH J
IPC: C07D253/06 , A61K31/519 , A61K31/52 , A61P29/00 , A61P35/00 , C07D473/34 , C07D487/04
Abstract: Described herein are irreversible kinase inhibitor compounds, methods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of diseases. Further described herein are methods, assays and systems for determining an appropriate irreversible inhibitor of a protein, including a kinase.
-
公开(公告)号:AU2009270856B2
公开(公告)日:2013-07-25
申请号:AU2009270856
申请日:2009-07-16
Applicant: PHARMACYCLICS LLC
Inventor: CHEN WEI , VERNER ERIK , LOURY DAVID , BUGGY JOSEPH , HONIGBERG LEE
Abstract: Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
-
-
-
-
-
-
-
-
-